Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT03954158. IPD Sharing: YES. Countries: 1. Publications: 0.
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension
ClinicalTrials.gov study NCT00847626. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer
ClinicalTrials.gov study NCT00959985. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT05785715. IPD Sharing: NO. Countries: 4. Publications: 0.
Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris
ClinicalTrials.gov study NCT01047189. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT01665430. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis
ClinicalTrials.gov study NCT02761993. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Predictive Value of Sleep Apnea-specific PTT Response for Incident Subclinical Abnormalities in LV Structure and Function in Cohort of moderate-to Severe OSA
ClinicalTrials.gov study NCT06626906. IPD Sharing: NO. Countries: 0. Publications: 12.
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03832738. IPD Sharing: NO. Countries: 3. Publications: 0.
A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT01089023. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment
ClinicalTrials.gov study NCT00999336. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
ClinicalTrials.gov study NCT06108544. IPD Sharing: YES. Countries: 16. Publications: 0.
Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate and Severe Nasolabial Folds
ClinicalTrials.gov study NCT02432742. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03864627. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment
ClinicalTrials.gov study NCT04887064. IPD Sharing: YES. Countries: 1. Publications: 0.
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT02002208. IPD Sharing: NO. Countries: 1. Publications: 0.
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
ClinicalTrials.gov study NCT02616250. IPD Sharing: Not stated. Countries: 2. Publications: 0.
An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease
ClinicalTrials.gov study NCT03650413. IPD Sharing: YES. Countries: 14. Publications: 0.
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus
ClinicalTrials.gov study NCT03288324. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease
ClinicalTrials.gov study NCT00207662. IPD Sharing: Not stated. Countries: 0. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.